Cyclopharm Limited (ASX:CYC)

Revenue by Segment

Financials in millions AUD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medical Imaging Systems	32.33M	27.57M	26.34M	-	-
Medical Imaging Systems Growth	17.24%	4.68%	-	-	-
Technegas	-	-	-	24.51M	19.74M
Technegas Growth	-	-	-	24.16%	12.65%
Molecular Imaging	-	-	-	340.46K	392.48K
Molecular Imaging Growth	-	-	-	-13.25%	156.38%
Total	32.33M	27.57M	26.34M	24.85M	20.14M
Total Growth	17.24%	4.68%	5.97%	23.43%	13.89%

Revenue by Geography

Financials in millions AUD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Asia Pacific	7.10M	7.99M	8.67M	9.54M	5.92M
Asia Pacific Growth	-11.20%	-7.82%	-9.10%	61.08%	9.78%
Europe	19.56M	15.85M	14.81M	12.17M	11.65M
Europe Growth	23.41%	6.97%	21.76%	4.42%	14.96%
Canada	2.36M	2.52M	2.74M	2.96M	2.46M
Canada Growth	-6.34%	-8.01%	-7.50%	20.50%	19.73%
United States Of America	2.70M	826.61K	-	-	-
United States Of America Growth	226.18%	-	-	-	-
Other	618.06K	389.00K	117.37K	299.98K	107.60K
Other Growth	58.89%	231.42%	-60.87%	178.79%	7.11%
Total	32.33M	27.57M	26.34M	24.96M	20.14M
Total Growth	17.24%	4.68%	5.51%	23.97%	13.89%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 25, 2026

Data Sources Report a data error